Published in Immunotherapy Weekly, December 23rd, 2009
"We hypothesized that HuMC express and secrete ANG in response to divergent stimuli. ANG expression was evaluated in the LAD2 HMC, the HMC-1, and CD34(+)-derived HuMC, following exposure to live Escherichia coli, TLR ligands, or neuropeptides and following Fc epsilon RI aggregation. Expression and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.